Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
555
-49,746
-99% -$17M 0.01% 274
2026
Q1
$17.7M Sell
50,301
-2,640
-5% -$941K 0.71% 31
2025
Q4
$17.3M Buy
52,941
+41,474
+362% +$13.2M 0.71% 26
2025
Q3
$3.24M Sell
11,467
-354
-3% -$103K 0.14% 80
2025
Q2
$3.3M Sell
11,821
-62
-0.5% -$17.6K 0.16% 72
2025
Q1
$3.7M Sell
11,883
-185
-2% -$54.6K 0.2% 58
2024
Q4
$3.15M Buy
12,068
+528
+5% +$157K 0.18% 70
2024
Q3
$3.72M Buy
11,540
+964
+9% +$315K 0.21% 54
2024
Q2
$3.3M Buy
10,576
+9,770
+1,212% +$2.87M 0.21% 50
2024
Q1
$229K Sell
806
-21
-3% -$6.14K 0.02% 205
2023
Q4
$238K Buy
827
+42
+5% +$11.4K 0.02% 183
2023
Q3
$211K Buy
+785
New +$196K 0.02% 172

Other funds holding AMGN

JB Capital's AMGN Position: Q2 2026 in Review

JB Capital reduced its Amgen (AMGN) stake by 99% in Q2 2026, selling an estimated $17M and leaving 555 shares worth $201K. The position accounts for 0.01% of the portfolio, ranked #274.

JB Capital first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $17.7M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • JB Capital held 555 shares of Amgen worth $201K as of Q2 2026.
  • JB Capital sold 49,746 Amgen shares in Q2 2026, an estimated $17M.
  • Amgen made up 0.01% of JB Capital's portfolio in Q2 2026, its #274 holding.
  • JB Capital first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • JB Capital's Amgen position peaked at $17.7M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.